Nutraceutix
- Company typePrivate
- Founded1990
- HeadquartersRedmond, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Nutraceutix does
Nutraceutix was a Redmond, Washington-based specialty pharmaceutical company that developed and commercialized probiotic supplements focused on digestive health and adjacent applications. Founded in 1983 and operating with a small team of 1-10 employees, the firm specialized in clinically validated probiotic strain development and manufacturing, with its proprietary LP299V® probiotic strain as the flagship ingredient. The company served business customers in the dietary supplement market, providing strains and formulations backed by an extensive clinical study library.
On June 6, 2016, Nutraceutix was acquired by Probi AB, a Swedish probiotic company, as part of a broader SEK 600 million rights issue. The transaction gave Probi a meaningful North American manufacturing footprint and customer base, and effectively ended Nutraceutix's status as an independent operating company — its website now redirects to Probi.com, and the brand has been absorbed into Probi's portfolio. Probi AB itself was subsequently taken over by Symrise Group, a German nutrition and health conglomerate, placing Nutraceutix two levels removed from standalone ownership.
The combined Probi/Nutraceutix business now offers a portfolio of clinically proven probiotic strains, postbiotic products, and probiotic spores across multiple health areas (digestive, immune, metabolic, mental, women's, healthy aging, kids', oral, sports) and end applications (dietary supplements, food and beverages, pet nutrition). Probi operates two US production sites — one of which is the former Nutraceutix Redmond facility — and distributes through a worldwide partner network spanning EMEA, APAC, and the Americas. Revenue and unit-economics data for the Nutraceutix sub-entity are not separately disclosed.
Nutraceutix firmographics
Firmographics- Name
- Nutraceutix
- Legal name
- Nutraceutix
- Website
- https://nutraceutix.com
- Company type
- Private
- Founded year
- 1990
- Operating status
- Acquired
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Nutraceutix industry classification
Industry- Product category
- Probiotic Manufacturing
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Pharmaceutical Preparations (2834), Food And Kindred Products (2000)
- akta.pro primary industry
- Probiotics (Strains, Spore-Formers, Synbiotic Components) (AFAJAKAE)
- akta.pro secondary industries
- Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases) (AFAJAJAE), Probiotics & Digestive Health Supplements (CRADAGAF)
Keywords
Where Nutraceutix is headquartered
LocationHeadquarters
- HQ city
- Redmond
- HQ country
- United States
- HQ region
- North America
Markets served
Nutraceutix business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales
Distribution channels1 record
Marketing channels1 record
Nutraceutix product offering
Product offeringCore offering
Nutraceutix develops and commercializes proprietary probiotic strains and solutions, including the patented LP299V® strain, for use in dietary supplements, food & beverages, and pet nutrition applications. Following its 2016 acquisition by Probi AB, the brand operates within Probi's portfolio of clinically documented probiotic and postbiotic offerings targeting digestive, immune, metabolic, mental, and women's health.
Product overview
Following Probi's 2016 acquisition of Nutraceutix, the combined company offers clinically proven probiotic strains and solutions. The portfolio includes the proprietary LP299V® probiotic strain, postbiotic products, and probiotic spores. Probi combines R&D expertise with manufacturing capabilities to deliver probiotic solutions across multiple health areas (Digestive Health, Immune Health, Metabolic Health, Women's Health, and more) serving applications in dietary supplements, food & beverages, and pet nutrition.
Differentiator
Problem solved
Functional benefit
Products and services
- LP299V® probiotic strain
Companies that use Nutraceutix
Customer profileSegments6 records
Ideal customer profiles1 record
Nutraceutix technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Nutraceutix partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- ProbicoreProbi acquired Nutraceutix on June 6, 2016, strongly expanding its North American presence and capabilities. Following the acquisition, Nutraceutix became part of Probi's operations, with users being redirected to Probi's website. The acquisition was announced as a press release and represents a significant strategic expansion for Probi in the North American probiotic market.
Scale indicators1 record
Recent moves4 records
Expansion highlights4 records
Nutraceutix competitors and assessment
Company assessmentDirect peers
- BioGaia: Swedish probiotic company commercializing clinically documented Lactobacillus reuteri strains for digestive, immune, and oral health. Directly comparable as a B2B probiotic strain supplier with strong clinical evidence positioning.
- Lesaffre: French yeast and fermentation specialist with a probiotic ingredient business (including Gnosis by Lesaffre) supplying documented strains for human and animal nutrition. Directly comparable as a fermentation-based probiotic strain supplier.
- Lallemand: Canadian-headquartered probiotic and yeast producer supplying documented probiotic strains for human and pet nutrition. Directly comparable as a probiotic ingredient/strain supplier with similar B2B model.
- Probi AB: Swedish probiotic strain and solution provider that acquired Nutraceutix in 2016. Operates in the same B2B probiotic strain and clinical-study-backed supplement space with overlapping product portfolios (including LP299V post-acquisition).
Broad incumbents
- Kerry Group (including Ganeden): Global taste and nutrition company with a probiotic ingredients platform (GanedenBC30) serving food, beverage, and supplement brands. Comparable as a broad incumbent offering branded, clinically backed probiotic ingredients.
- International Flavors & Fragrances (IFF, formerly DuPont Nutrition & Biosciences): Global ingredient major with a HOWARU probiotic portfolio supplying clinically documented strains to dietary supplement and food & beverage brands. Comparable as a broad incumbent in probiotic ingredients.
- Chr. Hansen (now Novonesis): Global leader in microbial and fermentation solutions including probiotic cultures for supplements, dairy, and infant nutrition. Comparable as a large-scale B2B supplier of clinically documented probiotic strains and cultures.
- DSM-Firmenich: Global nutrition and health ingredient major with a probiotic and gut-health portfolio serving dietary supplement and functional food customers. Comparable as a broad incumbent with probiotic offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Nutraceutix social profiles
Digital presenceNutraceutix financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nutraceutix leadership team
Management profileNumber of profiles
Nutraceutix funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nutraceutix M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nutraceutix
What does Nutraceutix do?
Nutraceutix develops and commercializes proprietary probiotic strains and solutions, including the patented LP299V® strain, for use in dietary supplements, food & beverages, and pet nutrition applications. Following its 2016 acquisition by Probi AB, the brand operates within Probi's portfolio of clinically documented probiotic and postbiotic offerings targeting digestive, immune, metabolic, mental, and women's health.
Is Nutraceutix a public or private company?
Nutraceutix is a private company. It is classified as corporate owned and is currently acquired.
When was Nutraceutix founded?
Nutraceutix was founded in 1990. It employs 101 to 250 people.
Where is Nutraceutix based?
Nutraceutix is headquartered in Redmond, United States, in the North America region.
Who are Nutraceutix's main competitors?
Direct peers on record are BioGaia, Lesaffre, Lallemand and Probi AB. Broad incumbents are Kerry Group (including Ganeden), International Flavors & Fragrances (IFF, formerly DuPont Nutrition & Biosciences), Chr. Hansen (now Novonesis) and DSM-Firmenich.
Does Nutraceutix have an API?
No public API is recorded for Nutraceutix.
What industry is Nutraceutix in?
Nutraceutix's product category is Probiotic Manufacturing. Its primary akta.pro industry code is AFAJAKAE, Probiotics (Strains, Spore-Formers, Synbiotic Components), with a secondary code of AFAJAJAE, Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases). Its NAICS code is 325414 and its SIC code is 2834.